The detection of TDP-43 alterations in muscle tissue has been a subject of interest in those TDP-43 proteinopathies directly related to neuromuscular diseases, especially ALS and IBM, highlighting a potential pathological role of TDP-43 in skeletal muscle [103]. This evidence concerns the gene TARDBP and inclusion body myositis.